Crossmark

Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology

Crossref DOI link: https://doi.org/10.1038/s41467-022-28496-1

Published Online: 2022-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wittenbecher, C. http://orcid.org/0000-0001-7792-877X
Cuadrat, R. http://orcid.org/0000-0001-8289-2599
Johnston, L. http://orcid.org/0000-0003-4169-2616
Eichelmann, F. http://orcid.org/0000-0002-3975-5596
Jäger, S. http://orcid.org/0000-0001-6619-0861
Kuxhaus, O.

Prada, M.

Del Greco M., F.

Hicks, A. A. http://orcid.org/0000-0001-6320-0411
Hoffman, P. http://orcid.org/0000-0002-6573-983X
Krumsiek, J.

Hu, F. B.

Schulze, M. B. http://orcid.org/0000-0002-0830-5277
License Information

Text and Data Mining valid from 2022-02-17

Version of Record valid from 2022-02-17
More Information

Article History

Received: 31 May 2020

Accepted: 26 January 2022

First Online: 17 February 2022

Competing interests

: The authors declare no competing interests.